ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,041.42
0.46%
Dow Jones
38,027.01
0.33%
US Dollar vs MXN
16.93485
-0.05%
Brent Oil
83.645
0.13%
Bitcoin
58,416.43
0.31%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Evogene Ltd (EVGN)

  7. Evogene Ltd (EVGN) Noticias

EVGN Evogene Ltd

0.7186
0.003 (0.42%)
Pre Mercado
Última actualización: 08:19:30
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Evogene Ltd EVGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.003 0.42% 0.7186 08:19:30
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.7156
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202406:00PRNUSBiomica to Present at the American Society of Clinical..
11/4/202406:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
02/4/202406:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
28/3/202408:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
20/3/202408:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
19/3/202408:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
13/3/202408:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
07/3/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202406:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202406:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
05/3/202406:00PRNUSCasterra Announces New Agreements with Seed Producers in..
01/3/202406:03EDGAR2Form F-3 - Registration statement by foreign private issuers
28/2/202406:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
26/2/202406:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
22/2/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202406:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
21/2/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202406:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
20/2/202406:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
14/2/202419:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202406:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
23/1/202406:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
17/1/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/1/202406:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
09/1/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202306:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
19/12/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202306:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
05/12/202306:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
28/11/202306:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
15/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202306:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
08/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202306:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
31/10/202306:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
18/10/202306:00PRNUSEvogene Provides Operational Update Amidst Current Security..
27/9/202306:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
21/9/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/9/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202306:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
15/8/202306:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
08/8/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202306:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
25/7/202306:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
19/7/202306:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
18/7/202313:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/7/202307:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
EVGN
Evogene
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados